Cystic Fibrosis: all 1,605 studies

Page 6 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic FibrosisCompletedNCT00528190Phase 4Results posted
• Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)CompletedNCT00513682Phase 3Results posted
• Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedNCT00510484Phase 3Results posted
• Deposition of Inhaled Prolastin in Cystic Fibrosis PatientsCompletedNCT00486837Phase 2Results posted
• A Study of Ataluren in Pediatric Participants With Cystic FibrosisCompletedNCT00458341Phase 2Results posted
• Safety Study of Ivacaftor in Subjects With Cystic FibrosisCompletedNCT00457821Phase 2Results posted
• Using Health-related Quality of Life (HRQL) in Routine Clinical CareCompletedNCT00457301Results posted
• Improving Vitamin D Status In Cystic FibrosisCompletedNCT00450073Not applicableResults posted
• A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)TerminatedNCT00434278Phase 4Results posted
• Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. AeruginosaCompletedNCT00431964Phase 4Results posted
• Nasally Delivered Pulmozyme for Sinusitis in Cystic FibrosisCompletedNCT00416182Phase 2Results posted
• Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)CompletedNCT00408317Phase 3Results posted
• Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic FibrosisCompletedNCT00391976Phase 3Results posted
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic FibrosisCompletedNCT00388505Phase 3Results posted
• Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary ExacerbationsCompletedNCT00381628Results posted
• A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.CompletedNCT00377741Phase 1Results posted
• Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00322868Not applicableResults posted
• Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic InsufficiencyCompletedNCT00297167Phase 3Results posted
• Behavioral & Nutritional Treatment to Help CF Preschoolers GrowCompletedNCT00241969Not applicableResults posted
• Effectiveness of Pulmozyme in Infants With Cystic FibrosisCompletedNCT00179998Phase 2Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)CompletedNCT00128492Phase 3Results posted
• International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00112359Phase 3Results posted
• EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionCompletedNCT00105183Phase 3Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedNCT00104520Phase 3Results posted
• Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic FibrosisCompletedNCT00097773Phase 2Results posted
• Impact of Trikafta on P2X7R and Clinical Outcomes in Cystic FibrosisCompletedNCT07841353
• Machine Learning Prediction of Pulmonary Function in Children With Cystic FibrosisCompletedNCT07770854
• Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator TherapyCompletedNCT07632768Phase 4
• Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of CareActive, not recruitingNCT07568119
• Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy ParticipantsCompletedNCT07349394Phase 1
• The School-Age Children With Cystic Fibrosis and Their Parents on Health LiteracyCompletedNCT07304362Not applicable
• ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory DiseasesCompletedNCT07175012Not applicable
• Exercise Capacity, Muscle Oxygenation, Respiratory Muscle Strength, and Physical Activity Level in Pediatric CF and PCDCompletedNCT07157644
• Upper Extremity Exercise Capacity, Muscle Oxygenation, and Balance in Pediatric CF and PCDCompletedNCT07148362
• Muscle Fatigue in People With Cystic Fibrosis: Insight From a Mobile AppCompletedNCT07135869
• Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaCompletedNCT07108153Phase 2
• Effectiveness of Respiratory Physiotherapy on Frequency of Exacerbations, Lung Function and Quality of Life After 6 Months in Children With Cystic FibrosisCompletedNCT07088614Not applicable
• Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.CompletedNCT07035990Phase 1
• PEP and O-PEP Device for Nebulization in Cystic FibrosisActive, not recruitingNCT06964074Not applicable
• A Prospective, Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) in Chinese Adults With Cystic FibrosisActive, not recruitingNCT06963008Early Phase 1
• A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)Active, not recruitingNCT06962852Phase 1/2
• Cell Content of Sputum Induced by Hypertonic Saline in Adolescents With Cystic FibrosisTerminatedNCT06909903Not applicable
• Antioxidant Supplements in Cystic Fibrosis ChildrenCompletedNCT06875050Not applicable
• A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet FormulationCompletedNCT06861413Phase 1
• Muscle Endurance in Children With Cystic FibrosisCompletedNCT06812793
• Assessing Tenapanor as a Treatment of CF-related Constipation.Active, not recruitingNCT06810167Phase 3
• The Effect of Telenursing on Self-efficacy and Treatment Adherence in Children With Cystic FibrosisCompletedNCT06660745Not applicable
• A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy SubjectsCompletedNCT06659757Phase 1
• Group Cognitive Behavioural Therapy for Adults With Cystic FibrosisCompletedNCT06645782Not applicable
• CGM Dynamic Index for Predicting Prediabetes in Cystic FibrosisCompletedNCT06642610Not applicable
• PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic FibrosisCompletedNCT06606457Not applicable
• Progressive Muscle Relaxation in Pulmonary Rehab for Quality of Life, Mental Health, and Sleep in Cystic FibrosisCompletedNCT06592742Not applicable
• Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic FibrosisCompletedNCT06565832Not applicable
• A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)TerminatedNCT06515002Phase 1/2
• Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)CompletedNCT06506773
• The Effect of Breathing Exercise With Pinwheel on the Quality of Life in Children With Cystic Fibrosis DiseaseCompletedNCT06482710Not applicable
• A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic FibrosisCompletedNCT06478706Phase 2
• Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CFCompletedNCT06468527Phase 2
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and OlderActive, not recruitingNCT06460506Phase 3
• Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)TerminatedNCT06399094
• Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic FibrosisActive, not recruitingNCT06371261
• Real World Environmental Exposure Study With Healthy and Cystic Fibrosis SubjectsWithdrawnNCT06339450Not applicable
• Effect of One Year Elexacaftor-tezacaftor-ivacaftor TreatmentCompletedNCT06331000
• Exercise in People With Cystic Fibrosis on CFTR Modulator TherapyActive, not recruitingNCT06322446Not applicable
• A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet FormulationCompletedNCT06312787Phase 1
• Effect of Parental Attitude on Functional and Physical Level of Children With Cystic FibrosisCompletedNCT06306508
• A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)CompletedNCT06299709Phase 1
• A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult PanelistsCompletedNCT06299696Phase 1
• Perceptions of the CF Screening Protocol Incorporating NGSCompletedNCT06299566
• Development,Validity and Reliability of a Caregiver Version of the Breathlessness Beliefs QuestionnaireCompletedNCT06289972
• An Intervention-Based Approach to Strengthen the Psychological Health of Children With Cystic Fibrosis and Their MothersCompletedNCT06280066Not applicable
• Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorCompletedNCT06255808
• Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy ChildrenCompletedNCT06242951
• Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas AeruginosaCompletedNCT06238856Phase 1
• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFActive, not recruitingNCT06237335Phase 2
• Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)Active, not recruitingNCT06222905
• Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy VolunteersCompletedNCT06217952Phase 1
• Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTORActive, not recruitingNCT06184763
• Assessment of Cognitive Function and Exercise Capacity in Cystic FibrosisCompletedNCT06175182
• A Study To Evaluate The Safety Of CMTX-101 In People With Cystic FibrosisCompletedNCT06159725Phase 1/2
• Evaluation of VX-828 in Healthy Participants and in Participants With Cystic FibrosisCompletedNCT06154447Phase 1
• Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic FibrosisCompletedNCT06147778Not applicable
• Development a Core Set for Adults With Cystic Fibrosis Based on the ICFCompletedNCT06128499
• Dynamic Chest X-ray With Simultaneous SpirometryCompletedNCT06122051
• Evaluation of Patient Access to People With Cystic Fibrosis (CF) and Healthcare ProfessionalsCompletedNCT06122025Not applicable
• YOGA-CF (Yoga Outcomes Get Assessed in Cystic Fibrosis)Active, not recruitingNCT06120465Not applicable
• The Application of the Self Care Deficit Nursing Theory in Adolescents With Cystic FibrosisCompletedNCT06112717Not applicable
• Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional StatusCompletedNCT06109675Not applicable
• A Study of the Clinical Benefit of Tobramycin Inhalation SolutionActive, not recruitingNCT06106789
• Cardiac Structure and Function in Patients with Cystic FibrosisActive, not recruitingNCT06084468
• Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric IntakeCompletedNCT06072365
• Airway Microbiome of Cystic Fibrosis PatientsActive, not recruitingNCT06057558Not applicable
• Lung Transplant READY CF 2: A Multi-site RCTActive, not recruitingNCT06030206Not applicable
• Cystic Fibrosis and Frailtyh What's in Common?CompletedNCT06020547
• A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung InfectionCompletedNCT06016088Phase 1/2
• The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic FibrosisCompletedNCT06012084Not applicable
• Predictors of Health Literacy in Adults With Cystic FibrosisCompletedNCT05963503
• Psychological Study in Children With MucoviscidosisCompletedNCT05948488
• The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic FibrosisCompletedNCT05944367
• ANNE Sensor Monitoring in Cystic FibrosisCompletedNCT05941832

← Cystic Fibrosis overview